Lin Miao

Prof. Lin Miao

State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
HYHuimin Yan
Huimin Yan
JLJia Lu
Jia Lu
JWJiabao Wang
Jiabao Wang
LCLu Chen
Lu Chen
YWYu Wang
Yu Wang
HZhan Zhang
han Zhang
Background and aims: Xuanfei Baidu decoction (XFBD), a traditional Chinese medicine formulation, was designed and successfully applied for COVID-19 disease treatment in China, while the mechanism is still not clear.Methods: To evaluate the protective effect of XFBD on immunosuppression in cyclophosphamide (CY)-treated mice, XFBD was orally administrated, the body weight was measured, and the immune organ index was calculated. HE staining was performed to analyze the pathological structures of the liver, spleen, and thymus. The levels of cytokines and immunoglobulin in the serum and spleen were evaluated by ELISA and RT-PCR. Splenic lymphocytes were isolated, and LPS-stimulated cell proliferation and the number of CD4+ and CD8+ T lymphocytes were evaluated.Results: XFBD significantly suppressed body weight loss and increased the indices of spleen and thymus. The pathological alteration was much improved after XFBD administration. The reductions of TNF-α, IFN-γ, IgG, and IgM levels in serum and IL-2, IL-4, and IL-6 expressions in the spleen were all significantly alleviated by XFBD. Splenic lymphocyte proliferation in response to LPS was further enhanced after treatment with XFBD. The reduction of CD4+ and CD8+ T lymphocytes in CY-treated mice was also highly increased in XFBD groups.Conclusion: Our findings suggested that XFBD played a crucial role in protection against immunosuppression in CY-treated mice and could be a potential candidate for immune modification and therapy.

1 September 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
Xueni WangXueni Wang
Xueni Wang
JZJunjie Zhu
Junjie Zhu
HYHuimin Yan
Huimin Yan
MSMengyao Shi
Mengyao Shi
QZQiaoqi Zheng
Qiaoqi Zheng
XGXiu-Mei Gao
Xiu-Mei Gao


1 September 2018 in Journal of Pharmacological Sciences
Verified
Journal Article
Open access
LMLin Miao
Lin Miao
XYXiaoting Yun
Xiaoting Yun
RTRui Tao
Rui Tao
YWYuefei Wang
Yuefei Wang
GFGuanwei Fan
Guanwei Fan
XGXiu-Mei Gao
Xiu-Mei Gao
Androgen-independent prostate cancer (PCa) is a developed tumor derived from the local androgen dependent PCa, which often affects elderly men. Psoralea corylifolia L, a traditional Chinese medicine, has been widely used for PCa treatment as an important part of a common prescription, while the mechanism remains unclear. Our study was aimed to investigate the tumor-inhibitory effect of its main component bakuchiol in androgen-independent PCa cell line PC-3 cells. Bakuchiol significantly suppressed PC-3 cell proliferation and migration; the expressions of PCNA and MMP-9 were consistently down regulated as well. Meanwhile, both the constitutive and LPS-induced NF-κB activation were significantly inhibited by bakuchiol. The inhibitory effects of bakuchiol on cell proliferation, migration and invasion were recovered when LPS were added together with bakuchiol. SiRNA against androgen receptor (AR) or estrogen receptor β (ERβ) were transfected and the regulation of bakuchiol-suppressed proliferation, invasion, NF-κB signaling and MMP-9 secretion in response to LPS were blocked. Taken together, our data demonstrated that bakuchiol inactivated NF-κB signaling via AR and ERβ, which contributes to inhibition of PC-3 cell proliferation and migration, indicating that bakuchiol is one of the key component from P. corylifolia L for PCa treatment and has a potential as anti-prostate cancer drug candidates.

1 October 2019 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
LMLin Miao
Lin Miao
CJChanyuan Jiao
Chanyuan Jiao
RSRui Shao
Rui Shao
YQYaxin Qi
Yaxin Qi
GFGuanwei Fan
Guanwei Fan
XGXiu-Mei Gao
Xiu-Mei Gao

17 December 2020 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
XYXiaolei Yu
Xiaolei Yu
WTWei Tan
Wei Tan
HGHan Gao
Han Gao
LMLin Miao
Lin Miao
XTXiaoxuan Tian
Xiaoxuan Tian
Herbal products play an important role globally in the pharmaceutical and healthcare industries. However, some specific groups of herbal products are easily adulterated by confused materials on the market, which seriously reduces the products’ quality. Universal conventional DNA barcodes would function poorly since the processed herbal products generally suffer from varying degrees of DNA degradation and DNA mixing during processing or manufacturing. For quality control purposes, an accurate and effective method should be provided for species identification of these herbal products. Here, we provided a strategy of developing the specific mini-barcode using Senna as an example, and by coupling with the metabarcoding technique, it realized the qualitative and quantitative identification of processed herbal products. The plastomes of Senna obtusifolia (L.) H.S.Irwin & Barneby and Senna occidentalis (L.) Link were newly assembled, and the hypervariable coding-regions were identified by comparing their genomes. Then, the specific mini-barcodes were developed based on the identified hypervariable regions. Finally, we applied the DNA metabarcoding technique to the developed mini-barcodes. Results showed that the lengths of plastomes of S. obtusifolia and S. occidentalis were 162,426 and 159,993 bp, respectively. Four hypervariable coding-regions ycf1, rpl23, petL, and matK were identified. Two specific mini-barcodes were successfully developed from matK, and the mini-barcode of primer 647F-847R was proved to be able to qualitatively and quantitatively identify these two processed Senna seeds. Overall, our study established a valuable way to develop the specific mini-barcode, which may provide a new idea for the quality control of processed herbal products.